Holen Sie sich die Stockscreener-App
0.2465
3.71%
-0.0095
Schlusskurs vom Vortag:
$0.256
Offen:
$0.2505
24-Stunden-Volumen:
155.98K
Relative Volume:
0.03
Marktkapitalisierung:
$2.07M
Einnahmen:
$1.23M
Nettoeinkommen (Verlust:
$-8.26M
KGV:
-0.00363
EPS:
-68
Netto-Cashflow:
$-9.08M
1W Leistung:
-0.96%
1M Leistung:
-20.48%
6M Leistung:
-39.12%
1J Leistung:
-89.28%
1-Tages-Spanne:
$0.24
$0.2594
1-Wochen-Bereich:
$0.24
$0.265
52-Wochen-Spanne:
$0.2202
$3.2099
Tivic Health Systems Inc Stock (TIVC) Company Profile
Firmenname
Tivic Health Systems Inc
Sektor
Branche
Telefon
(888)276-6888
Adresse
47685 LAKEVIEW BLVD, FREMONT
Vergleichen Sie TIVC mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TIVC
Tivic Health Systems Inc
|
0.2465 | 2.07M | 1.23M | -8.26M | -9.08M | -68.00 |
|
ABT
Abbott Laboratories
|
118.95 | 208.18B | 41.22B | 5.77B | 6.49B | 2.94 |
|
SYK
Stryker Corp
|
388.14 | 148.70B | 21.97B | 3.59B | 3.21B | 6.74 |
|
BSX
Boston Scientific Corp
|
90.75 | 133.32B | 15.91B | 1.79B | 1.89B | 0.82 |
|
MDT
Medtronic Plc
|
86.27 | 111.27B | 33.00B | 4.29B | 5.50B | 2.71 |
|
EW
Edwards Lifesciences Corp
|
72.07 | 42.66B | 6.60B | 4.16B | 490.10M | 2.34 |
Tivic Health Systems Inc Aktie (TIVC) Neueste Nachrichten
Tivic Health Systems, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Tivic Health Systems Third Quarter 2024 Earnings: US$0.23 loss per share (vs US$1.48 loss in 3Q 2023) - Yahoo Finance
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q3 2024 Earnings Call Transcript - Insider Monkey
Tivic Health Q3: 70% Gross Margins Achieved Despite Revenue Drop; Net Loss Narrows | TIVC Stock News - StockTitan
Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update - The Bakersfield Californian
Tivic Health Systems Reports Third Quarter 2024 Results - TipRanks
Tivic Health Systems Inc. (TIVC) Quarterly 10-Q Report - Quartzy
Enrollment Complete in Tivic Health Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - The Bakersfield Californian
Enrollment Complete in Tivic Health Optimization Study for Its Non-Invasive Vagus Nerve Stimulation Device - Marketscreener.com
Tivic Health Validates European Patents in Great Britain, Germany, and France - Marketscreener.com
Tivic Health Secures Key European Patents for ClearUP Sinus Treatment Technology | TIVC Stock News - StockTitan
U.S. Stock market: FOXO Technologies(+134.66%) Northann Corp.(+67.38%) and ProPhase Labs(-47.43%) were the most volatile stocks during midday trading - Business Upturn
U.S. Stock market: Tivic Health up 138.62%, Northann surges 120.19%, ProPhase Labs down 50.70% among the most volatile stocks during early trading - Business Upturn
Tivic Health Systems, Inc. to Report Third Quarter 2024 Financial Results on November 14 - Business Wire
First Subject Enrolled in Tivic Health’s Optimization Study for its Non-Invasive Vagus Nerve Stimulation Device - The Bakersfield Californian
Tivic Health CEO Jennifer Ernst to Present at New York BioFuture 2024 - Business Wire
Tivic Health's Non-Invasive Cervical Vagus Nerve Stimulation Approach Wins Study Approval - MPO-mag
Market Resilience: Tivic Health Systems Inc (TIVC) Finishes Weak at 0.23, Down -10.00 - The Dwinnex
A stock that deserves closer examination: Tivic Health Systems Inc (TIVC) - US Post News
What's Going On With Tivic Health Stock? - MSN
Tivic Health stock hits 52-week low at $0.23 amid market challenges - Investing.com
Tivic Health Systems Inc (TIVC) Stock: A Year of Market Fluctuations - The InvestChronicle
Tivic Health Systems Inc [TIVC] Stock trading around $0.26 per share: What’s Next? - The DBT News
Tivic Health Advances its Vagus Nerve Stimulation Commercial Strategy - MPO-mag
Lisa Wolf Named Interim CFO at Tivic Health - MPO-mag
electroCore (NASDAQ:ECOR) vs. Tivic Health Systems (NASDAQ:TIVC) Critical Survey - Defense World
There is no way Tivic Health Systems Inc (TIVC) can keep these numbers up - SETE News
Tivic Health advances in non-invasive nerve stimulation - Investing.com
Tivic Health Receives Approval from Institutional Review Board for ncVNS Optimization Study, Readies for Enrollment - Business Wire
Balance Sheet Breakdown: Tivic Health Systems Inc (TIVC)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Tivic Health partners with Fletcher Spaght for growth strategy - Investing.com
Tivic Health partners with Fletcher Spaght for growth strategy By Investing.com - Investing.com UK
Tivic Health Accelerates VNS Commercial Strategy Development - Business Wire
Tivic Health names Lisa Wolf as interim CFO - MSN
Tivic Health names Lisa Wolf as Interim CFO - TipRanks
Tivic Health Names Wolf Interim CFO - MarketWatch
Tivic Health Systems Initiates Stock Sale and Leadership Transition - TipRanks
Tivic Health Appoints Lisa Wolf as Interim Chief Financial Officer - StockTitan
Tivic Health stock hits 52-week low at $0.28 amid sharp decline - Investing.com
Tivic Health Advances Its Vagus Nerve Stimulation Commercial Strategy - MPO-mag
Market Watch: Tivic Health Systems Inc (TIVC)’s Noteworthy Gain, Closing at 0.33 - The Dwinnex
Tivic Health Granted U.S., European Patents - MPO-mag
Tivic Health Systems Inc (TIVC Stock: A Sea of Opportunity - The InvestChronicle
Financial Health Check: Examining Tivic Health Systems Inc (TIVC)’s Key Ratios - The Dwinnex
Tivic Health Systems, Inc. (NASDAQ:TIVC) Q2 2024 Earnings Call Transcript - Insider Monkey
Tivic Health expands equity incentive plan post-stockholder approval - Investing.com India
TIVC Stock Earnings: Tivic Health Systems Reported Results for Q2 2024 - InvestorPlace
Tivic Health Systems Q2 Financial Performance Overview - TipRanks
Tivic Health expands equity incentive plan post-stockholder approval By Investing.com - Investing.com Australia
Tivic Health Systems, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 - Marketscreener.com
Tivic Reports Second Quarter 2024 Financial Results - Business Wire
Finanzdaten der Tivic Health Systems Inc-Aktie (TIVC)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):